PFBT
BVS icon

Parkside Financial Bank & Trust’s Bioventus BVS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55
Closed -$504 – 2771
2025
Q1 		$504 Buy
+55
New +$549 ﹤0.01% 2382

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkside Financial Bank & Trust's BVS Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Bioventus (BVS) in Q2 2025, closing a stake of 55 shares — an estimated $504 sold.

Parkside Financial Bank & Trust first reported a position in BVS in Q1 2025 and held it in 1 quarter. The position peaked at $504 in Q1 2025. 134 funds tracked by Wall St. Rank hold BVS as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Bioventus position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 55 Bioventus shares in Q2 2025, an estimated $504.
  • Parkside Financial Bank & Trust first reported a position in Bioventus in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Bioventus position peaked at $504 in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Bioventus as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.